PMID: 18210826Jan 24, 2008Paper

Neuromyelitis optica: the disease entity, pathogenesis and therapy

Rinshō shinkeigaku = Clinical neurology
Kazuo Fujihara

Abstract

Neuromyelitis optica (NMO) is clinically characterized by severe optic neuritis and transverse myelitis. Recurrent NMO has been described as optic-spinal multiple sclerosis (OSMS) in Japan, but it has been known that NMO has distinct clinical and laboratory findings (female preponderance, severe disability, longitudinally extensive myelitis, CSF-pleocytosis, negative oligoclonal IgG bands, etc) from those in typical MS. In addition, anti-aquaporin-4 (AQP4) antibody and loss of AQP4 in the active perivascular NMO lesions with deposition of immunoglobulins and activated complements were recently found to be NMO-specific, strongly suggesting that NMO is a clinical entity that should be separated from MS. In accordance with these unique features of NMO, different therapeutic responses between NMO and MS have been observed, that is, interferon-beta, a disease-modifying therapy (DMT) for MS, is less effective in NMO, while long-term administration of corticosteroid and immunosuppressive agents reduce relapses of NMO. Efficacy of plasma exchange for acute exacerbation in NMO supports the pathogenetic importance of humoral immunity in the disease. Meanwhile, in clinical practice, it is important to differentiate "genuine OSMS" characte...Continue Reading

Related Concepts

Related Feeds

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Related Papers

Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology
Kazuo Fujihara
Rinshō shinkeigaku = Clinical neurology
Kazuo Fujihara
Journal of Neurology, Neurosurgery, and Psychiatry
Anu JacobJérôme de Seze
Brain and nerve = Shinkei kenkyū no shinpo
Yoshiki TakaiKazuo Fujihara
© 2021 Meta ULC. All rights reserved